본문 바로가기
KERD
논문KCI 등재

Green Synthesis of Copper Nano-Drug and Its Dental Application upon Periodontal Disease-Causing Microorganisms

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류생물학

초록

Dental pathogens lead to chronic diseases like periodontitis, which causes loss of teeth. Here, we examined the plausible antibacterial efficacy of copper nanoparticles (CuNPs) synthesized using Cupressus macrocarpa extract (CME) against periodontitis-causing bacteria. The antimicrobial properties of CME-CuNPs were then assessed against oral microbes (M. luteus. B. subtilis, P. aerioginosa) that cause periodontal disease and were identified using morphological/ biochemical analysis, and 16S-rRNA techniques. The CME-CuNPs were characterized, and accordingly, the peak found at 577 nm using UV–Vis spectrometer showed the formation of stable CME-CuNPs. Also, the results revealed the formation of spherical and oblong monodispersed CME-CuNPs with sizes ranged from 11.3 to 22.4 nm. The FTIR analysis suggested that the CME contains reducing agents that consequently had a role in Cu reduction and CME-CuNP formation. Furthermore, the CME-CuNPs exhibited potent antimicrobial efficacy against different isolates which was superior to the reported values in literature. The antibacterial efficacy of CME-CuNPs on oral bacteria was compared to the synergistic solution of clindamycin with CME-CuNPs. The solution exhibited a superior capacity to prevent bacterial growth. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and fractional inhibitory concentration (FIC) of CME-CuNPs with clindamycin recorded against the selected periodontal disease-causing microorganisms were observed between the range of 2.6–3.6 μg/ml, 4-5 μg/ml and 0.312-0.5, respectively. Finally, the synergistic antimicrobial efficacy exhibited by CME-CuNPs with clindamycin against the tested strains could be useful for the future development of more effective treatments to control dental diseases.

Abstract

Dental pathogens lead to chronic diseases like periodontitis, which causes loss of teeth. Here, we examined the plausible antibacterial efficacy of copper nanoparticles (CuNPs) synthesized using Cupressus macrocarpa extract (CME) against periodontitis-causing bacteria. The antimicrobial properties of CME-CuNPs were then assessed against oral microbes (M. luteus. B. subtilis, P. aerioginosa) that cause periodontal disease and were identified using morphological/ biochemical analysis, and 16S-rRNA techniques. The CME-CuNPs were characterized, and accordingly, the peak found at 577 nm using UV–Vis spectrometer showed the formation of stable CME-CuNPs. Also, the results revealed the formation of spherical and oblong monodispersed CME-CuNPs with sizes ranged from 11.3 to 22.4 nm. The FTIR analysis suggested that the CME contains reducing agents that consequently had a role in Cu reduction and CME-CuNP formation. Furthermore, the CME-CuNPs exhibited potent antimicrobial efficacy against different isolates which was superior to the reported values in literature. The antibacterial efficacy of CME-CuNPs on oral bacteria was compared to the synergistic solution of clindamycin with CME-CuNPs. The solution exhibited a superior capacity to prevent bacterial growth. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and fractional inhibitory concentration (FIC) of CME-CuNPs with clindamycin recorded against the selected periodontal disease-causing microorganisms were observed between the range of 2.6–3.6 μg/ml, 4-5 μg/ml and 0.312-0.5, respectively. Finally, the synergistic antimicrobial efficacy exhibited by CME-CuNPs with clindamycin against the tested strains could be useful for the future development of more effective treatments to control dental diseases.

참고문헌 (54)

  1. "Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.1789~8583
  2. Dias HB, "LED and low-level laser therapy association in tooth bleaching using a novel low concentration H2O2", N-doped TiO2 bleaching agent, 2016, pp.26, 015602~
  3. Petersen PE, "The global burden of periodontal disease: Towards integration with chronic disease prevention and control", Periodontol, 2000(60), pp.15~39 (2012)
  4. Chen X, "Advanced biomaterials and their potential applications in the treatment of periodontal disease", Crit. Rev. Biotechnol, 36, pp.760~775 (2016)
  5. Osorio R, "Bioactive polymeric nanoparticles for periodontal therapy", PLoS One, 11, pp.e0166217~ (2016)
  6. Knight ET, "Risk factors that may modify the innate and adaptive immune responses in periodontal diseases", Periodontol, 2000(71), pp.22~51 (2016)
  7. Souto R, "Prevalence of Pseudomonas aeruginosa and Acinetobacter spp. in subgingival biofilm and saliva of subjects with chronic periodontal infection", Braz. J. Microbiol, 45, pp.495~501 (2014)
  8. Viciani E, "Prevalence of M75 Streptococcus pyogenes strains harboring slaA gene in patients affected by pediatric obstructive sleep apnea syndrome in central Italy", Front. Microbiol, 8, pp.294~ (2017)
  9. Culotti A, "Pseudomonas aeruginosa promotes Escherichia coli biofilm formation in nutrient-limited medium", PLoS One, 9, pp.e107186~ (2014)
  10. Colombo AP, "Periodontal-disease-associated biofilm : a reservoir for pathogens of medical importance", Microb. Pathog, 94, pp.27~34 (2016)
  11. Sudiono J, "Bactericidal and cytotoxic effects of Erythrina fusca leaves aquadest extract", Dent. J. Majal. Kedokt. Gigi, 46, pp.9~13 (2013)
  12. Mah, TF, "Biofilm-specific antibiotic resistance", Future Microbiol, 7, pp.1061~1072 (2012)
  13. Victor T Noronha, "Silver nanoparticles in dentistry", Dent. Mater, 33, pp.1110~1126 (2017)
  14. Roshna T, "Generalized aggressive periodontitis and its treatment options : case reports and review of the literature", Case Rep. Med, 2012, pp.535321~ (2012)
  15. Michaud DS, "Periodontal disease, tooth loss, and cancer risk", Epidemiol. Rev, 39, pp.49~58 (2017)
  16. Rieuwpassa IE, "Effectiveness of clindamycin in treatment of Periodontitis", Indian J. Public Health Res. Dev, 10, pp.1223~ (2019)
  17. Wyszogrodzka G, "Metalorganic frameworks : mechanisms of antibacterial action and potential applications", Drug Discov. Today, 21, pp.1009~1018 (2016)
  18. Dφaz-Visurraga J, "A study on antibacterial alginate-stabilized copper nanoparticles by FT-IR and 2D-IR correlation spectroscopy", Int. J. Nanomed, 7, pp.3597~ (2012)
  19. Holla G, "Evaluation of minimum inhibitory and minimum bactericidal concentration of nano-silver base inorganic anti-microbial agent(Novaron)against Streptococcus mutans", Contemp. Clin. Dent, 3, pp.288~293 (2012)
  20. Greenstein G, "The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology", J. Periodontol, 71, pp.125~140 (2000)
  21. Rajeshkumar S, "Anticancer activity of eco-friendly gold nanoparticles against lung and liver cancer cells", J. Genet. Eng. Biotechnol, 14, pp.195~202 (2016)
  22. Podstawczyk D, "Reactivity of(+)-catechin with copper(II)ions : the green synthesis of size-controlled Sub-10 nm copper nanoparticles", ACS Sustain. Chem. Eng, 7, pp.17535~17543 (2019)
  23. Molnár Z, "Green synthesis of gold nanoparticles by thermophilic filamentous fungi", Sci. Rep, 8, pp.3943~ (2018)
  24. Salem MZM, "Bioactivity of essential oils extracted from Cupressus macrocarpa branchlets and Corymbia citriodora leaves grown in Egypt", BMC Complement Altern. Med, 18, pp.23~ (2018)
  25. Enan ET, "Antimicrobial activity of biosynthesized silver nanoparticles, Amoxicillin and glass-ionomer cement against Streptococcus mutans and Staphylococcus aureus", Nanotechnology, 32, pp.215101~ (2021)
  26. Yaqub A, "Novel biosynthesis of copper nanoparticles using Zingiber and Allium sp. with synergic effect of doxycycline for anticancer and bactericidal activity", Curr. Microbiol, 77, pp.2287~2299 (2020)
  27. Gad El-Rab SMF, "Biogenic synthesis of ZnO nanoparticles and its potential use as antimicrobial agent against multidrug-resistant pathogens", Curr. Microbiol, 77, pp.1767~1779 (2020)
  28. Sanaa M. F. Gad El-Rab, "Formulation of Ceftriaxone Conjugated Gold Nanoparticles and Their Medical Applications against Extended-Spectrum β-Lactamase Producing Bacteria and Breast Cancer", Journal of Microbiology and Biotechnology, 28(9), pp.1563~1572 (2018), 한국미생물·생명공학회
  29. Dubey SP, "Tansy fruit mediated greener synthesis of silver and gold nanoparticles", Process Biochem, 45, pp.1065~1071 (2010)
  30. Halawani EM, "Nanoformulation of biogenic cefotaxime-conjugated-silver nanoparticles for enhanced antibacterial efficacy against multidrug-resistant bacteria and anticancer studies", Int. J. Nanomed, 5, pp.1889~1901 (2020)
  31. John G, "Bergey's manual of determinative bacteriology", pp.20~ (1994), Williams & Wilkins
  32. MaccFadin JK, "Biochemical test for identification of medical bacteria" (2000), Lippincott Williams and Winkins, AwolterKlumer Company
  33. Kanmani P, "Synthesis and characterization of pullulan-mediated silver nanoparticles and its antimicrobial activities", Carbohydr. Polym, 12, pp.421~428 (2013)
  34. Iskandarsyah NH, "Sinergicity test of silver nanoparticles and clindamycin against Staphylococcus aureus", Int. J. Res. Pharm. Sci, 11, pp.1192~1198 (2020)
  35. Wu S, "Green synthesis of copper nanoparticles using Cissus vitiginea and its antioxidant and antibacterial activity against urinary tract infection pathogens", Artif. Cells Nanomed. Biotechnol, 48, pp.1153~1158 (2020)
  36. Joseph AT, "Phytofabrication and Characterization of copper nanoparticles using Allium sativum and its antibacterial activity", Int. J. Sci. Eng. Technol, 4, pp.463~472 (2016)
  37. Sengan M, "N-myristoyltaurine capped copper nanoparticles for selective colorimetric detection of Hg2+ in wastewater and as effective chemocatalyst for organic dye degradation", Microchem. J, 148, pp.1~9 (2019)
  38. Suarez-Cerda J, "A green synthesis of copper nanoparticles using native cyclodextrins as stabilizing agents", J. Saudi Chem. Soc, 21, pp.341~348 (2017)
  39. Fan D, "Synthesis, thermal conductivity and anti-oxidation properties of copper nanoparticles encapsulated within few-layer h-BN", Ceram. Int, 44, pp.1205~1208 (2018)
  40. Dutta D, "Nanoporous montmorillonite clay stabilized copper nanoparticles : efficient and reusable catalyst for oxidation of alcohols", Mol. Catal, 451, pp.178~185 (2018)
  41. Gurunathan S, "Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli", Colloids Surf. B, 74, pp.328~335 (2009)
  42. Harraz FM, "From natural product research chemical constituents, Antibacterial and Acetylcholine esterase inhibitory activity of Cupressus macrocarpa leaves", Nat. Prod. Res, 34, pp.816~822 (2018)
  43. Fuloria NK, "Response of green synthesized drug blended silver nanoparticles against periodontal disease triggering pathogenic microbiota", J. Appl. Biol. Biotechnol, 7, pp.46~56 (2019)
  44. Emmanuel R, "Antimicrobial efficacy of green synthesized drug blended silver nanoparticles against dental caries and periodontal disease-causing microorganisms", Mater. Sci. Eng. C, 56, pp.374~379 (2015)
  45. Li Y, "Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles", ACS Nano, 6, pp.5164~5173 (2012)
  46. Chatterjee AK, "Mechanism of antibacterial activity of copper nanoparticles", Nanotechnology, 25, pp.135101~ (2014)
  47. Arumugam A, "Synthesis of cerium oxide nanoparticles using Gloriosa superba L. leaf extract and their structural, optical and antibacterial properties", Mater. Sci. Eng. C, 49, pp.408~415 (2015)
  48. Mandava K, "Green synthesis of stable copper nanoparticles and synergistic activity with antibiotics", Indian J. Pharm. Sci, 79, pp.695~700 (2017)
  49. Gad El-RabSMF, "Biosynthesis of silver nano-drug using Juniperus excelsa and its synergistic antibacterial activity against multidrug-resistant bacteria for wound dressing applications", 3 Biotech, 11, pp.255~ (2021)
  50. Patel BH, "Biosynthesis of copper nanoparticles; its characterization and efficacy against human pathogenic bacterium", J. Environ. Chem. Eng, 4, pp.2163~2169 (2016)
  51. Hassanien R, "Biosynthesis of copper nanoparticles using aqueous Tilia extract : antimicrobial and anticancer activities", Heliyon, 4, pp.e01077~ (2018)
  52. Rajeshkumar S, "Antibacterial and antioxidant potential of biosynthesized copper nanoparticles mediated through Cissus arnotiana plant extract", J. Photochem. Photobiol. B, 197, pp.111531~ (2019)
  53. Covarrubias C, "Synthesis of hybrid copper-chitosan nanoparticles with antibacterial activity against cariogenic Streptococcus mutans", Dent. Mater. J, 37, pp.379~384 (2018)
  54. Mardones J, "In vitro antibacterial properties of copper nanoparticles as endodontic medicament against Enterococcus faecalis", J. Dent. Oral Disord, 4, pp.1107~ (2018)

관련 논문AI추천

이 간행물의 다른 논문 (7건)